Literature DB >> 24785219

Intussusception risk after rotavirus vaccination in U.S. infants.

Guilhem Noel1, Philippe Minodier, Thierry Merrot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24785219     DOI： 10.1056/NEJMc1402790

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Hospitalization rates for intussusception in children aged 0-59 months from 2009 to 2014 in Italy.

Authors:  Vincenzo Restivo; Claudio Costantino; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-01-11       Impact factor: 3.452

2.  Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure.

Authors:  Efe Eworuke; Emily C Welch; Anne Tobenkin; Judith C Maro
Journal:  Drug Saf       Date:  2019-07       Impact factor: 5.606

Review 3.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

5.  A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.

Authors:  Prasad S Kulkarni; Sajjad Desai; Tushar Tewari; Anand Kawade; Nidhi Goyal; Bishan Swarup Garg; Dinesh Kumar; Suman Kanungo; Veena Kamat; Gagandeep Kang; Ashish Bavdekar; Sudhir Babji; Sanjay Juvekar; Byomkesh Manna; Shanta Dutta; Rama Angurana; Deepika Dewan; Abhijeet Dharmadhikari; Jagdish K Zade; Rajeev M Dhere; Alan Fix; Maureen Power; Vidyasagar Uprety; Varsha Parulekar; Iksung Cho; Temsunaro R Chandola; Vikash K Kedia; Abhishek Raut; Jorge Flores
Journal:  Vaccine       Date:  2017-09-26       Impact factor: 3.641
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.